Ein Mann liest Wirtschaftsnachrichten (Symbolbild).
Donnerstag, 22.08.2013 16:20 von | Aufrufe: 100

BeesFree Signs Second Manufacturing Agreement to Supply United States Market with BeesVita Plus

Ein Mann liest Wirtschaftsnachrichten (Symbolbild). pixabay.com

PR Newswire

WEST PALM BEACH, Fla., Aug. 22, 2013 /PRNewswire/ -- BeesFree, Inc. (OTC QB: BEES) continues to position itself as the world leader in creating, manufacturing and marketing an effective treatment for the treatment of Colony Collapse Disorder (CCD) by announcing a manufacturing agreement with Form-A-Feed Inc. to supply the entire United States market with BeesVita Plus™. With an operating history of over 40 years, Minnesota-based Form-A-Feed (http://www.formafeed.com) employs over 100 people through 9 divisions with a focus on introducing new ideas, concepts and products to the livestock industry.

BeesVita Plus™ is an innovative composite food supplement for honeybees that strengthens the bee's immune system and prevents the effects of Colony Collapse Disorder (CCD). The agreement with Form-A-Feed covers the process development and manufacturing of BeesVita Plus for the United States market. Production is expected to begin in the third quarter.

"Adding an additional manufacturer for another one of our major marketplaces will help to prevent any bottlenecks in the supply in the years ahead," commented Dr. Andrea Festuccia Ph.D., Chairman of BeesFree. "Additionally, establishing a commercial manufacturing agreement with such a respected company will ensure quality control within our manufacturing process as we embark on a rapid rollout of BeesVita Plus™ over the next 12 months."

Joseph N. Fasciglione, Interim Chief Executive Officer and Interim Chief Financial Officer of BeesFree stated, "Having now achieved one of our key objectives, we are now prepared to move into the commercialization phase of our operation. As sales ramp up over the coming months, we anticipate generating revenues upward of $3 million over the next twelve months."

About BeesFree, Inc.
BeesFree, Inc. (OTC QB: BEES) is a company focused on developing innovative solutions for the global beekeeping community owns a patent pending composite food solution that helps honeybees avoid the effects of Colony Collapse Disorder (CCD).  Visit www.beesfree.biz to learn more about why the bees are disappearing, and how beekeepers can combat the honey bee decline.

Forward-Looking Statements
Statements about the future expectations of BeesFree, Inc. and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as that term is defined in the Private Securities Litigation Reform Act of 1995. BeesFree, Inc. intends that such forward-looking statements shall be subject to the safe harbors created thereby. Since these statements involve certain risks and uncertainties and are subject to change at any time, Bees Free actual results could differ materially from expected results.


ARIVA.DE Börsen-Geflüster

Kurse

-  
0,00%
Beesfree Chart

Contact:
Name:  Joseph N. Fasciglione Interim Chief Executive Officer
Number: (561) 939-4860

Email: j.fasciglione@beesfree.biz

SOURCE BeesFree, Inc.

Werbung

Mehr Nachrichten zur Beesfree Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Andere Nutzer interessierten sich auch für folgende News